Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial.
Heerspink HJL, Stack AG, Terkeltaub R, Jongs N, Inker LA, Bjursell M, Maklad N, Perl S, Eklund O, Rikte T, Sjöström CD, Perkovic V; SAPPHIRE Investigators. Heerspink HJL, et al. J Am Soc Nephrol. 2024 May 1;35(5):594-606. doi: 10.1681/ASN.0000000000000326. Epub 2024 Feb 20. J Am Soc Nephrol. 2024. PMID: 38564654 Clinical Trial. No abstract available.
Advanced materials provide solutions towards a sustainable world.
Hultman L, Mazur S, Ankarcrona C, Palmqvist A, Abrahamsson M, Antti ML, Baltzar M, Bergström L, de Laval P, Edman L, Erhart P, Kloo L, Lundberg MW, Mikkelsen A, Moons E, Persson C, Rensmo H, Rosén J, Rudén C, Selleby M, Sundgren JE, Dick Thelander K, Tybrandt K, Weihed P, Zou X, Åstrand M, Björkman CP, Schneider JM, Eriksson O, Berggren M. Hultman L, et al. Among authors: mazur s. Nat Mater. 2024 Feb;23(2):160-161. doi: 10.1038/s41563-023-01778-9. Nat Mater. 2024. PMID: 38307974 No abstract available.
Challenges and opportunities for research supporting cumulative impact assessments at the United States environmental protection agency's office of research and development.
Tulve NS, Geller AM, Hagerthey S, Julius SH, Lavoie ET, Mazur SL, Paul SJ, Frey HC. Tulve NS, et al. Among authors: mazur sl. Lancet Reg Health Am. 2024 Jan 11;30:100666. doi: 10.1016/j.lana.2023.100666. eCollection 2024 Feb. Lancet Reg Health Am. 2024. PMID: 38292929 Free PMC article. Review. No abstract available.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Lee AW, Liu K, Lhomme E, Blie J, McCullough J, Onorato MT, Connor L, Simon JK, Dubey S, VanRheenen S, Deutsch J, Owens A, Morgan A, Welebob C, Hyatt D, Nair S, Hamzé B, Guindo O, Sow SO, Beavogui AH, Leigh B, Samai M, Akoo P, Serry-Bangura A, Fleck S, Secka F, Lowe B, Watson-Jones D, Roy C, Hensley LE, Kieh M, Coller BG; PREVAC Study Team. Lee AW, et al. Clin Infect Dis. 2024 Apr 10;78(4):870-879. doi: 10.1093/cid/ciad693. Clin Infect Dis. 2024. PMID: 37967326 Free PMC article. Clinical Trial.
223 results